Resource Use in Diabetes Patients with Neuropathy and Depression
Author Information
Author(s): Le Trong K, Able Stephen L, Lage Maureen J
Primary Institution: Eli Lilly and Company
Hypothesis
This research aims to compare medical resources used by patients with diabetes, diabetic neuropathy, and diabetes with depression.
Conclusion
Patients with diabetic neuropathy or depression incur significantly higher medical costs compared to those with diabetes alone.
Supporting Evidence
- Patients with diabetic neuropathy had total medical costs over five times higher than those with diabetes alone.
- The study found significant differences in medication use among the three cohorts.
- Individuals with diabetes and depression had higher total medical costs compared to those with diabetes alone.
Takeaway
People with diabetes and additional problems like nerve pain or depression spend a lot more on medical care than those with just diabetes.
Methodology
The study analyzed data from a large health insurance database, comparing costs and medication use among three patient cohorts.
Potential Biases
Potential bias due to reliance on diagnostic codes rather than formal assessments.
Limitations
The study used administrative claims data, which may not be generalizable and lacks formal diagnostic assessments.
Participant Demographics
The majority of patients were commercially insured, with a mix of genders and regions, and the DD cohort was predominantly female.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website